{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:16:00Z","timestamp":1763547360858,"version":"3.45.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004320","name":"Shiraz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004320","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"DOI":"10.1186\/s13104-025-07555-y","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:13:14Z","timestamp":1763547194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Linalool as a potential agent against Toxoplasma gondii: an in vitro study"],"prefix":"10.1186","volume":"18","author":[{"given":"Kimia","family":"Goudarzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keivan","family":"Sahebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Zandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qasem","family":"Asgari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh","family":"Askari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aref","family":"Teimouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"12\u201313","key":"7555_CR1","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","volume":"30","author":"AM Tenter","year":"2000","unstructured":"Tenter AM, Heckeroth AR, Weiss LM. Toxoplasma gondii: from animals to humans. Int J Parasitol. 2000;30(12\u201313):1217\u201358.","journal-title":"Int J Parasitol"},{"issue":"4","key":"7555_CR2","first-page":"443","volume":"17","author":"A Teimouri","year":"2022","unstructured":"Teimouri A, Goudarzi F, Goudarzi K, Alimi R, Sahebi K, Foroozand H, Keshavarz H. Toxoplasma gondii infection in immunocompromised patients in Iran (2013\u20132022): A systematic review and Meta-Analysis. Iran J Parasitol. 2022;17(4):443\u201357.","journal-title":"Iran J Parasitol"},{"issue":"1","key":"7555_CR3","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1756-3305-3-112","volume":"3","author":"JP Webster","year":"2010","unstructured":"Webster JP, Dubey JP. Toxoplasmosis of animals and humans. Parasites Vectors. 2010;3(1):112.","journal-title":"Parasites Vectors"},{"issue":"4","key":"7555_CR4","first-page":"898","volume":"36","author":"A Molan","year":"2019","unstructured":"Molan A, Nosaka K, Hunter M, Wang W. Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots. Trop Biomed. 2019;36(4):898\u2013925.","journal-title":"Trop Biomed"},{"issue":"9425","key":"7555_CR5","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"JG Montoya","year":"2004","unstructured":"Montoya JG, Liesenfeld O, Toxoplasmosis. Lancet. 2004;363(9425):1965\u201376.","journal-title":"Lancet"},{"issue":"1","key":"7555_CR6","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1186\/s12879-025-11231-8","volume":"25","author":"F Javvi","year":"2025","unstructured":"Javvi F, Sahebi K, Asgari Q, Mikaeili F, Teimouri A. Clinical courses and outcomes of cerebral toxoplasmosis in HIV-positive patients in Shiraz, Southern iran: a retrospective study. BMC Infect Dis. 2025;25(1):817.","journal-title":"BMC Infect Dis"},{"key":"7555_CR7","doi-asserted-by":"crossref","unstructured":"Teimouri A, Shima M, Atefeh B, Keivan S, Hassan F, Gholamreza H, Hossein K. Current and emerging techniques for diagnosis of toxoplasmosis in pregnancy: A narrative review. Iran J Parasitol. 2024;19(4):384.","DOI":"10.18502\/ijpa.v19i4.17159"},{"issue":"1","key":"7555_CR8","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/14760584.2023.2157818","volume":"22","author":"X Zhang","year":"2023","unstructured":"Zhang X, Yuan H, Mahmmod YS, Yang Z, Zhao M, Song Y, et al. Insight into the current Toxoplasma gondii DNA vaccine: a review Article. Expert Rev Vaccines. 2023;22(1):66\u201389.","journal-title":"Expert Rev Vaccines"},{"issue":"4","key":"7555_CR9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/pathogens12040543","volume":"12","author":"J Layton","year":"2023","unstructured":"Layton J, Theiopoulou D-C, Rutenberg D, Elshereye A, Zhang Y, Sinnott J, et al. Clinical spectrum, radiological findings, and outcomes of severe toxoplasmosis in immunocompetent hosts: A systematic review. Pathogens. 2023;12(4):543.","journal-title":"Pathogens"},{"key":"7555_CR10","doi-asserted-by":"crossref","unstructured":"Dunay IR, Gajurel K, Dhakal R, Liesenfeld O, Montoya JG. Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice. Clin Microbiol Rev. 2018;31(4).","DOI":"10.1128\/CMR.00057-17"},{"key":"7555_CR11","doi-asserted-by":"crossref","unstructured":"Montazeri M, Mehrzadi S, Sharif M, Sarvi S, Tanzifi A, Aghayan SA, Daryani A. Drug resistance in Toxoplasma gondii. Front Microbiol. 2018;9:2587.","DOI":"10.3389\/fmicb.2018.02587"},{"issue":"8","key":"7555_CR12","doi-asserted-by":"publisher","first-page":"e2400039","DOI":"10.1002\/jobm.202400039","volume":"64","author":"HBA Baghdadi","year":"2024","unstructured":"Baghdadi HBA, Albalawi AE, Shater AF, Almohammed H, Alanazi AD. Linalool-zinc oxide nanocomposite controls Toxoplasma gondii infection through inhibiting inflammation, oxidative stress, and pathogenicity. J Basic Microbiol. 2024;64(8):e2400039.","journal-title":"J Basic Microbiol"},{"issue":"1","key":"7555_CR13","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12906-024-04522-1","volume":"24","author":"K Sahebi","year":"2024","unstructured":"Sahebi K, Shahsavani F, Mehravar F, Hatam G, Alimi R, Radfar A, et al. In vitro and in vivo anti-parasitic activity of curcumin nanoemulsion on Leishmania major (MRHO\/IR\/75\/ER). BMC Complement Med Ther. 2024;24(1):238.","journal-title":"BMC Complement Med Ther"},{"issue":"7","key":"7555_CR14","doi-asserted-by":"publisher","first-page":"e144346","DOI":"10.5812\/semj-144346","volume":"25","author":"K Goudarzi","year":"2024","unstructured":"Goudarzi K, Alimi R, Zarghami T, Bahreini MS, Ghanimatdan M, Sharifdini M, et al. In vitro scolicidal effect of Urtica dioica and Pyrus boissieriana extracts against protoscoleces of Echinococcus granulosus. Shiraz E-Med J. 2024;25(7):e144346.","journal-title":"Shiraz E-Med J"},{"key":"7555_CR15","doi-asserted-by":"crossref","unstructured":"Yao N, He J-K, Pan M, Hou Z-F, Xu J-J, Yang Y et al. In vitro evaluation of Lavandula angustifolia essential oil on Anti-Toxoplasma activity. Front Cell Infect Microbiol. 2021;11:755715.","DOI":"10.3389\/fcimb.2021.755715"},{"issue":"3","key":"7555_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s11694-016-9341-0","volume":"10","author":"N Zamindar","year":"2016","unstructured":"Zamindar N, Sadrarhami M, Doudi M. Antifungal activity of coriander (Coriandrum sativum L.) essential oil in tomato sauce. J Food Meas Charact. 2016;10(3):589\u201394.","journal-title":"J Food Meas Charact"},{"issue":"21","key":"7555_CR17","doi-asserted-by":"publisher","first-page":"10370","DOI":"10.1039\/D1FO02120F","volume":"12","author":"Q An","year":"2021","unstructured":"An Q, Ren J-N, Li X, Fan G, Qu S-S, Song Y, et al. Recent updates on bioactive properties of linalool. Food Funct. 2021;12(21):10370\u201389.","journal-title":"Food Funct"},{"issue":"19","key":"7555_CR18","doi-asserted-by":"publisher","first-page":"6625","DOI":"10.1007\/s00253-022-12172-x","volume":"106","author":"Y-N Li","year":"2022","unstructured":"Li Y-N, Zhang S-B, Lv Y-Y, Zhai H-C, Cai J-P, Hu Y-S. Mechanisms underlying the inhibitory effects of linalool on Aspergillus flavus spore germination. Appl Microbiol Biotechnol. 2022;106(19):6625\u201340.","journal-title":"Appl Microbiol Biotechnol"},{"issue":"6","key":"7555_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1111\/myc.12606","volume":"60","author":"KVS Silva","year":"2017","unstructured":"Silva KVS, Lima MIO, Cardoso GN, Santos AS, Silva GS, Pereira FO. Inibitory effects of linalool on fungal pathogenicity of clinical isolates of Microsporum canis and Microsporum gypseum. Mycoses. 2017;60(6):387\u201393.","journal-title":"Mycoses"},{"key":"7555_CR20","doi-asserted-by":"crossref","unstructured":"Medeiros CIS, Sousa MNAD, Filho GGA, Freitas FOR, Uchoa DPL, Nobre MSC et al. Antifungal activity of linalool against fluconazole-resistant clinical strains of vulvovaginal Candida albicans and its predictive mechanism of action. Braz J Med Biol Res. 2022;55:e11831.","DOI":"10.1590\/1414-431x2022e11831"},{"key":"7555_CR21","doi-asserted-by":"crossref","unstructured":"Huang S-Y, Yao N, He J-K, Pan M, Hou Z-F, Fan Y-M et al. In vitro Anti-parasitic activity of Pelargonium X. asperum essential oil against Toxoplasma gondii. Front Cell Dev Biology. 2021;9:616340.","DOI":"10.3389\/fcell.2021.616340"},{"issue":"4","key":"7555_CR22","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3390\/molecules26040819","volume":"26","author":"RM Shaapan","year":"2021","unstructured":"Shaapan RM, Al-Abodi HR, Alanazi AD, Abdel-Shafy S, Rashidipour M, Shater AF, Mahmoudvand H. Myrtus communis essential Oil; Anti-parasitic effects and induction of the innate immune system in mice with Toxoplasma gondii infection. Molecules. 2021;26(4):819.","journal-title":"Molecules"},{"issue":"null","key":"7555_CR23","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.2147\/IJN.S158736","volume":"13","author":"A Teimouri","year":"2018","unstructured":"Teimouri A, Azami SJ, Keshavarz H, Esmaeili F, Alimi R, Mavi SA, Shojaee S. Anti-Toxoplasma activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain. Int J Nanomed. 2018;13(null):1341\u201351.","journal-title":"Int J Nanomed"},{"issue":"null","key":"7555_CR24","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.2147\/IJN.S181896","volume":"13","author":"SJ Azami","year":"2018","unstructured":"Azami SJ, Teimouri A, Keshavarz H, Amani A, Esmaeili F, Hasanpour H, et al. Curcumin nanoemulsion as a novel chemical for the treatment of acute and chronic toxoplasmosis in mice. Int J Nanomed. 2018;13(null):7363\u201374.","journal-title":"Int J Nanomed"},{"issue":"4","key":"7555_CR25","doi-asserted-by":"publisher","first-page":"312","DOI":"10.4103\/0972-9062.197262","volume":"53","author":"A Teimouri","year":"2016","unstructured":"Teimouri A, Haghi AM, Nateghpour M, Farivar L, Hanifian H, Mavi SA, Zare R. Antimalarial efficacy of low molecular weight chitosan against Plasmodium Berghei infection in mice. J Vector Borne Dis. 2016;53(4):312\u20136.","journal-title":"J Vector Borne Dis"},{"issue":"1","key":"7555_CR26","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/s41598-024-84131-7","volume":"15","author":"K Sahebi","year":"2025","unstructured":"Sahebi K, Takallu S, Foroozand H, Amirsoleymani M, Sadjjadi SM, Sharifi Y, et al. Piperine-loaded mesoporous silica nanoparticles as a promising strategy for targeting Echinococcus granulosus protoscoleces. Sci Rep. 2025;15(1):520.","journal-title":"Sci Rep"},{"issue":"6","key":"7555_CR27","first-page":"e01734","volume":"68","author":"AE Albalawi","year":"2024","unstructured":"Albalawi AE, Shater AF, Alanazi AD, Alsulami MN, Almohammed HI. High potency of linalool-zinc oxide nanocomposite as a new agent for cystic echinococcosis treatment. Antimicrob Agents Chemother. 2024;68(6):e01734\u201323.","journal-title":"Antimicrob Agents Chemother"},{"key":"7555_CR28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.actatropica.2016.08.026","volume":"164","author":"FL Dutra","year":"2016","unstructured":"Dutra FL, Oliveira MM, Santos RS, Silva WS, Alviano DS, Vieira DP, Lopes AH. Effects of linalool and eugenol on the survival of Leishmania (L.) infantum Chagasi within macrophages. Acta Trop. 2016;164:69\u201376.","journal-title":"Acta Trop"},{"issue":"2","key":"7555_CR29","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1590\/0074-02760160361","volume":"112","author":"LH Villamizar","year":"2017","unstructured":"Villamizar LH, Cardoso MDG, Andrade JD, Teixeira ML, Soares MJ. Linalool, a piper aduncum essential oil component, has selective activity against Trypanosoma Cruzi trypomastigote forms at 4\u00b0C. Mem\u00f3rias Do Instituto Oswaldo Cruz. 2017;112(2):131\u20139.","journal-title":"Mem\u00f3rias Do Instituto Oswaldo Cruz"},{"issue":"11","key":"7555_CR30","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.3390\/molecules24112072","volume":"24","author":"MR Youssefi","year":"2019","unstructured":"Youssefi MR, Moghaddas E, Tabari MA, Moghadamnia AA, Hosseini SM, Farash BRH, et al. In vitro and in vivo effectiveness of carvacrol, thymol and linalool against Leishmania infantum. Molecules. 2019;24(11):2072.","journal-title":"Molecules"},{"key":"7555_CR31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.24193\/subbchem.2024.1.08","volume":"69","author":"I Ciotlaus","year":"2024","unstructured":"Ciotlaus I, Ana B, Fenesan M, Filip M, Mihaela V. GC-MS and HPLC chromatographic profile of majority volatile and phenolic compounds of some medicinal plants from Romania. Studia Universitatis Babe\u0219-Bolyai Chem. 2024;69:121\u201345.","journal-title":"Studia Universitatis Babe\u0219-Bolyai Chem"},{"key":"7555_CR32","doi-asserted-by":"publisher","first-page":"123454","DOI":"10.1016\/j.envpol.2024.123454","volume":"345","author":"X Yao","year":"2024","unstructured":"Yao X, Cheng Z, Agathokleous E, Wei Y, Feng X, Li H, et al. Tetracycline and sulfadiazine toxicity in human liver cells Huh-7. Environ Pollut. 2024;345:123454.","journal-title":"Environ Pollut"},{"key":"7555_CR33","doi-asserted-by":"crossref","unstructured":"Gomaa M, Gad W, Hussein D, Pottoo FH, Tawfeeq N, Alturki M et al. Sulfadiazine exerts potential anticancer effect in HepG2 and MCF7 cells by inhibiting TNF\u03b1, IL1b, COX-1, COX-2, 5-LOX gene expression: evidence from in vitro and computational studies. Pharmaceuticals (Basel). 2024;17(2):189.","DOI":"10.3390\/ph17020189"},{"issue":"3","key":"7555_CR34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1365-2184.2004.00307.x","volume":"37","author":"A Prashar","year":"2004","unstructured":"Prashar A, Locke IC, Evans CS. Cytotoxicity of lavender oil and its major components to human skin cells. Cell Prolif. 2004;37(3):221\u20139.","journal-title":"Cell Prolif"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07555-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-025-07555-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-025-07555-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T10:13:17Z","timestamp":1763547197000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/s13104-025-07555-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7555"],"URL":"https:\/\/doi.org\/10.1186\/s13104-025-07555-y","relation":{},"ISSN":["1756-0500"],"issn-type":[{"type":"electronic","value":"1756-0500"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"11 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the research ethics committee of Shiraz University of Medical Sciences with the ethical code IR.SUMS.AEC.1402.039.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not available.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"488"}}